Biomaterials company Bucha Bio raises $1.1M to accelerate its growth

US-based biomaterials company Bucha Bio, has raised 1.1 million dollars in seed money to accelerate its growth.

The US company declared that it will put the money toward building out its lab and offices, scaling up its supplies, and growing its staff.

New Climate Ventures, Lifely VC, Beni VC, Prithvi VC, Asymmetry VC, and investors from the Glasswall Syndicate were among the investors in the seed round.

Zimri Hinshaw, the CEO and founder of Bucha Bio, said that he was looking to develop a brand in the fashion market but couldn’t find any materials that connected well with his sustainable ideals and the plant-based lifestyle.

Two biobased materials are currently being developed by SHORAI™ and HIKARI™. SHORAI™. Animal leather, plastic leather, and other synthetic materials can all be substituted with SHORAI™. The newest product, HIKARI™, will be fully unveiled in November of this year. It has a translucent look and special processing skills. In addition to growing their technical staff, BUCHA BIO intends to keep developing additional applications for their technology, such as biocomposites, biopackaging, and hard fibers. The fashion, automotive, home goods, electronics, and construction industries all apply. The ultimate objective of BUCHA BIO is to internally develop novel material concepts from concept to final product using a library of biobased components, a prototype production line, and the company’s primary bacterial nanocellulose technology.